Skip to main content
. Author manuscript; available in PMC: 2021 Jun 9.
Published in final edited form as: Nature. 2020 Dec 9;588(7839):705–711. doi: 10.1038/s41586-020-2998-x

Extended Data Figure 7. Reelin is efficiently deleted in RelnΔLEC/ΔLEC cardiac-associated lymphatics.

Extended Data Figure 7.

a, Immunostaining of E17.5 control and RelnΔLEC/ΔLEC heart sections with antibodies against Reelin and Lyve1 confirms that Reelin is deleted from cardiac lymphatics in RelnΔLEC/ΔLEC hearts (TAM injected at E13.5 and E14.5). N = 3 embryos/genotype from 2 separate litters. Control embryos are TAM treated Cre- embryos and Cre+; Reln+/+embryos. b, Co-immunostaining with antibodies against Vimentin, PECAM1, CD68, Six2 and Hnf4α, together with EdU labeling shows comparable proliferation of cardiac fibroblasts, blood endothelial cells and macrophages, and of nephron progenitors and hepatocytes between controls and E17.5 RelnΔLEC/ΔLEC hearts (TAM injected at E13.5 and E14.5). White arrows indicate EdU+ proliferating cells. Quantification of the proliferation for each of those cell types is shown on the right panels. N = 3 embryos/genotype from 2 separate litters. Control embryos are TAM treated Cre- and Cre+;Reln+/+ littermates. Data are presented as mean ± S.E.M. n.s. not significant difference by unpaired two-tailed Student’s t test. Scale bar, 25 μm.